Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noffar Bar

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.
The Lancet. Haematology|July 4, 2020
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional studyGeorge Goshua, Alexander B Pine, Matthew L Meizlish, et al.
Blood Advances|January 4, 2018
Whole-exome sequencing in evaluation of patients with venous thromboembolismEun-Ju Lee, Daniel J Dykas, Andrew D Leavitt, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.
The Lancet. Haematology|July 4, 2020
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional studyGeorge Goshua, Alexander B Pine, Matthew L Meizlish, et al.
Blood Advances|January 4, 2018
Whole-exome sequencing in evaluation of patients with venous thromboembolismEun-Ju Lee, Daniel J Dykas, Andrew D Leavitt, et al.
Pageof 3